UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 325

Sortiert nach

Rivaroxaban vs. Warfarin in Japanese Patients With Atrial Fibrillation: The J-ROCKET AF Study

Circulation Journal, 2012, Vol.76(9), pp.2104-2111

2012

Link zum Volltext

Verfügbarkeit prüfen

Baseline Demographics and Clinical Characteristics in the All Nippon AF in the Elderly (ANAFIE) Registry

Circulation Journal, 2019/06/25, Vol.83(7), pp.1538-1545

2019

Link zum Volltext

Verfügbarkeit prüfen

Leveraging fine-mapping and multipopulation training data to improve cross-population polygenic risk scores

Nature genetics, 2022-04, Vol.54 (4), p.450-458

2022

Link zum Volltext

Verfügbarkeit prüfen

Guidelines for Pharmacotherapy of Atrial Fibrillation (JCS 2013): Digest Version

Circulation Journal, 2014/07/25, Vol.78(8), pp.1997-2021

Group, JCS Joint Working

2014

Link zum Volltext

Verfügbarkeit prüfen

Short-Term Safety and Plasma Concentrations of Edoxaban in Japanese Patients With Non-Valvular Atrial Fibrillation and Severe Renal Impairment

Circulation Journal, 2015/06/25, Vol.79(7), pp.1486-1495

2015

Link zum Volltext

Verfügbarkeit prüfen

Edoxaban vs. Warfarin in East Asian Patients With Atrial Fibrillation　– An ENGAGE AF-TIMI 48 Subanalysis

Circulation Journal, 2016/03/25, Vol.80(4), pp.860-869

2016

Link zum Volltext

Verfügbarkeit prüfen

Comparative Safety and Effectiveness of Apixaban vs. Warfarin in Oral Anticoagulant-Naïve Japanese Patients With Non-Valvular Atrial Fibrillation　― A Retrospective Chart Review Study

Circulation Journal, 2022/01/25, Vol.86(2), pp.213-221

2022

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Edoxaban in Elderly Patients With Atrial Fibrillation in the ENGAGE AF–TIMI 48 Trial

Journal of the American Heart Association, 2016-05, Vol.5 (5), p.n/a

2016

Link zum Volltext

Verfügbarkeit prüfen

Randomized, Multicenter, Warfarin-Controlled Phase II Study of Edoxaban in Japanese Patients With Non-Valvular Atrial Fibrillation

Circulation Journal, 2012, Vol.76(8), pp.1840-1847

2012

Link zum Volltext

Verfügbarkeit prüfen

Effect of Cancer on Clinical Outcomes in Elderly Patients With Non-Valvular Atrial Fibrillation　― Substudy of the ANAFIE Registry

Circulation Journal, 2022/01/25, Vol.86(2), pp.202-210

2022

Link zum Volltext

Verfügbarkeit prüfen

Safety and effectiveness of edoxaban in Japanese patients with nonvalvular atrial fibrillation: Final report of a two‐year postmarketing surveillance study (ETNA‐AF‐Japan)

Journal of arrhythmia, 2021-04, Vol.37 (2), p.370-383

2021

Link zum Volltext

Verfügbarkeit prüfen

Leveraging supervised learning for functionally informed fine-mapping of cis-eQTLs identifies an additional 20,913 putative causal eQTLs

Nature communications, 2021-06, Vol.12 (1), p.3394-3394, Article 3394

2021

Link zum Volltext

Verfügbarkeit prüfen

Postmarketing surveillance on the clinical use of edoxaban in patients with nonvalvular atrial fibrillation (ETNA‐AF‐Japan): One‐year safety and effectiveness analyses

Journal of arrhythmia, 2020-06, Vol.36 (3), p.395-405

2020

Link zum Volltext

Verfügbarkeit prüfen

Echocardiographic Structure and Function in Elderly Patients With Atrial Fibrillation in Japan　― The ANAFIE Echocardiographic Substudy

Circulation Journal, 2022/01/25, Vol.86(2), pp.222-232

2022

Link zum Volltext

Verfügbarkeit prüfen

Relationship Between Direct Oral Anticoagulant Doses and Clinical Outcomes in Elderly Patients With Non-Valvular Atrial Fibrillation　― ANAFIE Registry Sub-Analysis

Circulation Journal, 2023/11/24, Vol.87(12), pp.1765-1774

2023

Link zum Volltext

Verfügbarkeit prüfen

Effects of Regional Differences in Asia on Efficacy and Safety of Edoxaban Compared With Warfarin　– Insights From the ENGAGE AF-TIMI 48 Trial

Circulation Journal, 2015/11/25, Vol.79(12), pp.2560-2567

2015

Link zum Volltext

Verfügbarkeit prüfen

Rivaroxaban vs. Warfarin in Japanese Patients With Non-Valvular Atrial Fibrillation in Relation to Age: Insight From J-ROCKET AF

Circulation Journal, 2014, Vol.78(6), pp.1349-1356

2014

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness and safety of long-term dabigatran among patients with non-valvular atrial fibrillation in clinical practice: J-dabigatran surveillance

Journal of cardiology, 2019-06, Vol.73 (6), p.507-514

2019

Link zum Volltext

Verfügbarkeit prüfen

Treatment strategy of dabigatran etexilate following the availability of idarucizumab in Japanese patients with non-valvular atrial fibrillation: J-Dabigatran Surveillance 2

Journal of cardiology, 2022-09, Vol.80 (3), p.255-260

2022

Link zum Volltext

Verfügbarkeit prüfen

Causes of Death in Elderly Patients With Non-Valvular Atrial Fibrillation　― Results From the ANAFIE Registry

Circulation Journal, 2023/06/23, Vol.87(7), pp.957-963

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 325

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(278)
Mit Volltextzugriff
(313)

Publikationsform

Sprache

Englisch
(317)
Japanisch
(66)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(199)
Life Sciences & Biomedicine
(182)
Humans
(142)
Cardiovascular System & Cardiology
(130)
Male
(106)
Cardiac & Cardiovascular Systems
(103)
Female
(100)
Aged
(94)
Middle Aged
(84)
Atrial Fibrillation
(77)
Risk Factors
(49)
Atrial Fibrillation - Drug Therapy
(44)
Stroke
(41)
Patients
(40)
Adult
(37)
Peripheral Vascular Disease
(35)
Aged, 80 And Over
(34)
Anticoagulants
(34)
Japan
(34)
Mortality
(33)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Rivaroxaban vs. Warfarin in Japanese Patients With Atrial Fibrillation: The J-ROCKET AF Study

Baseline Demographics and Clinical Characteristics in the All Nippon AF in the Elderly (ANAFIE) Registry

Leveraging fine-mapping and multipopulation training data to improve cross-population polygenic risk scores

Guidelines for Pharmacotherapy of Atrial Fibrillation (JCS 2013): Digest Version

Short-Term Safety and Plasma Concentrations of Edoxaban in Japanese Patients With Non-Valvular Atrial Fibrillation and Severe Renal Impairment

Edoxaban vs. Warfarin in East Asian Patients With Atrial Fibrillation　– An ENGAGE AF-TIMI 48 Subanalysis

Comparative Safety and Effectiveness of Apixaban vs. Warfarin in Oral Anticoagulant-Naïve Japanese Patients With Non-Valvular Atrial Fibrillation　― A Retrospective Chart Review Study

Efficacy and Safety of Edoxaban in Elderly Patients With Atrial Fibrillation in the ENGAGE AF–TIMI 48 Trial

Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial

Randomized, Multicenter, Warfarin-Controlled Phase II Study of Edoxaban in Japanese Patients With Non-Valvular Atrial Fibrillation

Target International Normalized Ratio Values for Preventing Thromboembolic and Hemorrhagic Events in Japanese Patients With Non-Valvular Atrial Fibrillation: Results of the J-RHYTHM Registry

Effect of Cancer on Clinical Outcomes in Elderly Patients With Non-Valvular Atrial Fibrillation　― Substudy of the ANAFIE Registry

Safety and effectiveness of edoxaban in Japanese patients with nonvalvular atrial fibrillation: Final report of a two‐year postmarketing surveillance study (ETNA‐AF‐Japan)

Leveraging supervised learning for functionally informed fine-mapping of cis-eQTLs identifies an additional 20,913 putative causal eQTLs

Clinical phenotypes of older adults with non-valvular atrial fibrillation not treated with oral anticoagulants by hierarchical cluster analysis in the ANAFIE Registry

Postmarketing surveillance on the clinical use of edoxaban in patients with nonvalvular atrial fibrillation (ETNA‐AF‐Japan): One‐year safety and effectiveness analyses

Echocardiographic Structure and Function in Elderly Patients With Atrial Fibrillation in Japan　― The ANAFIE Echocardiographic Substudy

Relationship Between Direct Oral Anticoagulant Doses and Clinical Outcomes in Elderly Patients With Non-Valvular Atrial Fibrillation　― ANAFIE Registry Sub-Analysis

Age-Related Differences in the Clinical Characteristics and Treatment of Elderly Patients With Atrial Fibrillation in Japan　― Insight From the ANAFIE (All Nippon AF In Elderly) Registry

Effects of Regional Differences in Asia on Efficacy and Safety of Edoxaban Compared With Warfarin　– Insights From the ENGAGE AF-TIMI 48 Trial

Rivaroxaban vs. Warfarin in Japanese Patients With Non-Valvular Atrial Fibrillation in Relation to Age: Insight From J-ROCKET AF

Echocardiographic Parameters of Left Atrial Structure and Function and Clinical Outcomes at 2 Years in Elderly Patients With Atrial Fibrillation　― The ANAFIE Echocardiographic Substudy

Effectiveness and safety of long-term dabigatran among patients with non-valvular atrial fibrillation in clinical practice: J-dabigatran surveillance

Treatment strategy of dabigatran etexilate following the availability of idarucizumab in Japanese patients with non-valvular atrial fibrillation: J-Dabigatran Surveillance 2

Causes of Death in Elderly Patients With Non-Valvular Atrial Fibrillation　― Results From the ANAFIE Registry

Suchergebnisse filtern